Nigeria’s 54gene, the health technology company advancing African genomics research for improved global health outcomes, has announced the launch of its diagnostic arm 7RiverLabs. Building on that vision, 54gene has domesticated diagnostic technology, eliminating the need for samples to be sent abroad for analysis. Physicians will now be able to detect and prevent diseases earlier, thereby helping to improve patients’ treatment outcomes and quality of health. “Launching 7RiverLabs is a manifestation of one of the goals 54gene set out to achieve two years ago – to improve diagnostic and treatment outcomes on the continent. With the range of tests 7RiverLabs offers, millions of Africans can begin to take greater control of their health.

Source: The North Africa Journal December 20, 2021 09:04 UTC